ISB News

Spotlight: Christine Pham

Christine Pham, 2016 ISB High School Intern, was accepted by WSU’s Honors College and was named a Distinguished Regents Scholar, which awarded her a four-year tuition scholarship.

“ISB saw the potential in me when I had not realized it myself. Working with multiple mentors and lab partners fostered my growth as an individual. As I head to college with the hopes of pursuing an interdisciplinary subject, I will build upon my knowledge of working with complex systems at ISB to help solve tomorrow’s issues. I will always cherish the connections I have made and look to my mentors as my role models in science. Dr. Baliga’s dedication to educating the youth is incomparable, and ISB will have a special place in my heart as I cannot thank ISB enough for the invaluable foundations I learned.”

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.